Empower Pharmacy hasnt changed how it serves patients and providers since before the shortage was declared over, Noorian said, and he expects demand to keep growing regardless of the litigation
Retatrutide vs Tirzepatide Tirzepatide adds GIP receptor activation to the GLP-1 mechanism, producing average weight loss of 20.9% at 15 mg over 72 weeks
Patients should monitor for signs of hypoglycemia, especially if taking other glucose-lowering medications, and have a plan in place to quickly correct low blood sugar when needed (such as consuming glucose tablets or a fast-acting carbohydrate)
On their starting point
Gastrointestinal adverse events, principally nausea, diarrhea, and vomiting, were the most frequently reported findings, consistent with the incretin-agonist class
[5] However, patient experience reports and online forums suggest that some individuals do notice feeling colder during treatment